Intelligent Photonics

Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.

Find out more about our technology

waveguide-home

Transforming Minimal access Surgeries Through Advanced Visualization

Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.

precision-efficiency-safety

Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash

SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to which Stryker will acquire all of the outstanding shares of Invuity for $7.40 per share in cash, implying a total equity value of approximately $190 million. "The combination of Stryker's established leadership in minimal access surgery paired with Invuity’s suite of enabling visualization and surgical devices should facilitate better patient outcomes and operating room efficiencies in women’s health...

Read More

Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures

SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the full commercial launch of PhotonGuide® Adapt, a novel system that consists of a flexible illuminator and a family of compatible retractors for surgical procedures performed vaginally including pelvic organ prolapse repairs and vaginal hysterectomies. PhotonGuide Adapt represents a new platform for Invuity. The flexible nature of the waveguide conforms to different sizes and shapes of retractors, and allows surgeons to seamlessly adjust the illumination along the length of the retractor to accommodate the surgical target....

Read More

Invuity Announces 2018 Second Quarter, Six-Month Financial Results

SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six months ended June 30, 2018. Q2 2018 Highlights Second quarter 2018 revenue grew 7.5% to $10.5 million compared to revenue of $9.8 million in the second quarter of 2017. Disposable revenue in the second quarter of 2018 grew 11.5% to $9.2 million compared to $8.3 million in the second quarter of 2017. Net loss for the second quarter 2018 was $9.0 million compared to net loss of $10.4 million in the second quarter of 2017. “During the quarter we completed our strate...

Read More

Testimonials

“The light improves my visualization in the surgical field, allowing me to be more precise with my bone cuts and joint preparation”

Selene Parekh, MD
North Carolina Orthopaedic Clinic
Durham, NC

“This is revolutionary technology that will change the way we do minimally invasive breast surgery. It is simply must have instrumentation to work more confident, and efficient in delicate anatomy.”

Lorraine Tafra, MD
Director of Breast Center
Anne Arundel Medical Center
Annapolis, MD

“These retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”

Rache Simmons, MD
New York Presbyterian/Weill Cornell Medical Center
New York, NY